Literature DB >> 19833798

Smart MR imaging agents relevant to potential neurologic applications.

C S Bonnet1, E Tóth.   

Abstract

Molecular imaging is aimed at the noninvasive visualization of the expression and function of bioactive molecules that often represent specific molecular signatures in disease processes. Any molecular imaging procedure requires an imaging probe that is specific to a given molecular event, which puts an important emphasis on chemistry development. In MR imaging, the past years have witnessed significant advances in the design of molecular agents, though most of these efforts have not yet progressed to in vivo studies. In this review, we present some examples relevant to potential neurobiologic applications. Our aim was to show what chemistry can bring to the area of molecular MR imaging with a focus on the 2 main classes of imaging probes: Gd(3+)-based and PARACEST agents. We will discuss responsive probes for the detection of metal ions such as Ca, Zn, Fe, and Cu, pH, enzymatic activity, and oxygenation state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833798      PMCID: PMC7963996          DOI: 10.3174/ajnr.A1753

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  69 in total

1.  A novel europium(III)-based MRI contrast agent.

Authors:  S Zhang; P Winter; K Wu; A D Sherry
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

2.  Novel pH-reporter MRI contrast agents.

Authors:  Silvio Aime; Daniela Delli Castelli; Enzo Terreno
Journal:  Angew Chem Int Ed Engl       Date:  2002-11-15       Impact factor: 15.336

3.  Selective sensing of zinc ions with a PARACEST contrast agent.

Authors:  Robert Trokowski; Jimin Ren; Ferenc Krisztián Kálmán; A Dean Sherry
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-28       Impact factor: 15.336

Review 4.  Paramagnetic lanthanide complexes as PARACEST agents for medical imaging.

Authors:  Mark Woods; Donald E Woessner; A Dean Sherry
Journal:  Chem Soc Rev       Date:  2006-05-10       Impact factor: 54.564

Review 5.  What we can do and what we cannot do with fMRI.

Authors:  Nikos K Logothetis
Journal:  Nature       Date:  2008-06-12       Impact factor: 49.962

Review 6.  Neuroprotective therapy for Parkinson's disease.

Authors:  W C Koller
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

7.  Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis.

Authors:  John W Chen; Wellington Pham; Ralph Weissleder; Alexei Bogdanov
Journal:  Magn Reson Med       Date:  2004-11       Impact factor: 4.668

Review 8.  Microenvironment-induced cancer metastasis.

Authors:  E K Rofstad
Journal:  Int J Radiat Biol       Date:  2000-05       Impact factor: 2.694

9.  Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.

Authors:  Anurag Mishra; Petra Fousková; Goran Angelovski; Edina Balogh; Anil K Mishra; Nikos K Logothetis; Eva Tóth
Journal:  Inorg Chem       Date:  2008-01-01       Impact factor: 5.165

10.  The synthesis and in vitro testing of a zinc-activated MRI contrast agent.

Authors:  Jody L Major; Giacomo Parigi; Claudio Luchinat; Thomas J Meade
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

View more
  7 in total

1.  On the Synthesis of 1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane.

Authors:  Bhumasamudram Jagadish; Gayle L Brickert-Albrecht; Gary S Nichol; Eugene A Mash; Natarajan Raghunand
Journal:  Tetrahedron Lett       Date:  2011-04-27       Impact factor: 2.415

2.  Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.

Authors:  Eunsoo Yoo; Huaitzung A Cheng; Lauren E Nardacci; David J Beaman; Charles T Drinnan; Carmen Lee; Kenneth W Fishbein; Richard G Spencer; Omar Z Fisher; Amber L Doiron
Journal:  Colloids Surf B Biointerfaces       Date:  2017-07-18       Impact factor: 5.268

3.  Bimodal MR-PET agent for quantitative pH imaging.

Authors:  Luca Frullano; Ciprian Catana; Thomas Benner; A Dean Sherry; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-22       Impact factor: 15.336

Review 4.  Activatable T₁ and T₂ magnetic resonance imaging contrast agents.

Authors:  Chuqiao Tu; Elizabeth A Osborne; Angelique Y Louie
Journal:  Ann Biomed Eng       Date:  2011-02-18       Impact factor: 3.934

5.  The effect of regioisomerism on the coordination chemistry and CEST properties of lanthanide(III) NB-DOTA-tetraamide chelates.

Authors:  Jacqueline R Slack; Mark Woods
Journal:  J Biol Inorg Chem       Date:  2013-11-28       Impact factor: 3.358

6.  Self-assembled polymeric nanoparticles as new, smart contrast agents for cancer early detection using magnetic resonance imaging.

Authors:  Fouzi Mouffouk; Teresa Simão; Daniel F Dornelles; André D Lopes; Pablo Sau; Jorge Martins; Khalid M Abu-Salah; Salman A Alrokayan; Ana M Rosa da Costa; Nuno R dos Santos
Journal:  Int J Nanomedicine       Date:  2014-12-17

7.  Novel nanomedicine with a chemical-exchange saturation transfer effect for breast cancer treatment in vivo.

Authors:  Yanlong Jia; Chaochao Wang; Jiehua Zheng; Guisen Lin; Dalong Ni; Zhiwei Shen; Baoxuan Huang; Yan Li; Jitian Guan; Weida Hong; Yuanfeng Chen; Renhua Wu
Journal:  J Nanobiotechnology       Date:  2019-12-17       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.